NCT05767229View on ClinicalTrials.gov

Acute Hemodynamic Response to Carvedilol in Children With Clinically Significant Portal Hypertension.

NACompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

March 13, 2023

Primary Completion Date

November 2, 2024

Study Completion Date

November 2, 2024

Conditions

Portal Hypertension

Interventions

DRUG

Carvedilol

Carvedilol 0.2 mg/kg for 1.5 hrs

Trial Locations (1)

110070

Institute of Liver & Biliary Sciences, New Delhi

All Listed Sponsors

lead

Institute of Liver and Biliary Sciences, India

OTHER